(Paperback)

This book uses multiple methods to consider flaws in the current regulation of direct-to-consumer advertising, using Mercks launch of Gardasil as a primary case study. It offers a specific way forward for both regulators of Big Pharma as well as scholars of mass communication.

(Hardback)

This book uses multiple methods to consider flaws in the current regulation of direct-to-consumer advertising, using Mercks launch of Gardasil as a primary case study. It offers a specific way forward for both regulators of Big Pharma as well as scholars of mass communication.